Innovative OTC drug for the treatment of irritable bowel syndrome (IBS). CannabIBS sp. z o.o. (PL) in cooperation with Greenspace Labs Inc. (USA) is conducting a pilot clinical trial to prove safety and efficacy of novel non-psychoactive cannabinoid-based treatment for IBS